期刊文献+

量子点成像技术在宫颈癌及卵巢癌诊断和治疗中的应用 被引量:2

下载PDF
导出
摘要 宫颈癌及卵巢癌都是目前严重威协女性健康的妇科恶性肿瘤,发病呈日益年轻化且发病率有逐年上升趋势。有数据统计,全世界每年约有宫颈癌新发病例50万,约有2313万妇女死于该病,其中80%的新发病例是发生在发展中国家,而我国每年宫颈癌新发病例约占全世界发病人数的1/3。
出处 《中国医学影像学杂志》 CSCD 北大核心 2014年第11期873-876,共4页 Chinese Journal of Medical Imaging
基金 国家自然科学基金项目(81201691) 江西省教育厅基金项目(GJJ13093)
  • 相关文献

参考文献25

  • 1申茹萌,洪颖,金敏.子宫颈癌筛查方法的选择[J].中国实用妇科与产科杂志,2010,26(2):157-159. 被引量:31
  • 2Lin HW,Tu YY,Lin SY,et al.Risk of ovarian cancer in women with pelvic inflammatory disease:a population-based study.Lancet Oncol,2011,12(9):900-904.
  • 3彭卫军,蒋朝霞.影像学诊断方法在妇科肿瘤中的应用[J].中国癌症杂志,2012,22(6):441-446. 被引量:23
  • 4杨雪,于宁,李翔.经阴道彩色多普勒超声联合血清CA125监测卵巢癌新辅助化疗的疗效[J].中国医学影像学杂志,2013,21(3):234-237. 被引量:13
  • 5高淑平.宫颈癌诊断与治疗的新进展[J].医学理论与实践,2012,25(12):1446-1448. 被引量:19
  • 6Guo Z,Hao T,Du S,et al.Multiplex electrochemiluminescence immunoassay of two tumor markers using multicolor quantum dots as labels and graphene as conducting bridge.Biosens Bioelectron,2013,44:101-107.
  • 7Cheng FF,Liang GX,Shen YY,et al.N-Acetylglucosamine biofunctionalized Cd Se Te quantum dots as fluorescence probe for specific protein recognition.Analyst,2013,138(2):666-670.
  • 8Jokerst JV,Raamanathan A,Christodoulides N,et al.Nanobio-chips for high performance multiplexed protein detection:determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels.Biosens Bioelectron,2009,24(12):3622-3629.
  • 9Al-Ogaidi I,Gou H,Aguilar ZP,et al.Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots.Chem Commun(Camb),2014,50(11):1344-1346.
  • 10Zrazhevskiy P,Gao X.Quantum dot imaging platform for singlecell molecular profiling.Nat Commun,2013,4:1619.

二级参考文献38

  • 1尚慧玲,李光仪,王刚,林铁成.子宫内膜癌术前MRI及PET的诊断价值[J].中国妇产科临床杂志,2004,5(4):271-272. 被引量:5
  • 2凌斌.子宫颈癌诊断与治疗的新进展[J].中国实用妇科与产科杂志,2007,23(1):23-25. 被引量:66
  • 3杨运胜,高国兰,杨心凤,马莹,卜照香,胡爱民,刘晓昱.晚期卵巢癌术前新辅助化疗的临床研究[J].实用癌症杂志,2007,22(3):302-304. 被引量:11
  • 4张莉.CT与MR对女性盆腔肿块诊断能力的对比研究[J].实用医学影像杂志,2007,8(3):175-177. 被引量:5
  • 5zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account[ J ]. Virology ,2009,384 ( 2 ) :260- 265.
  • 6Yoon JH, Yoo SC, Kim WY ,et al. Role of HPV DNA testing for detection of high-grade cervical lesions in women with atypical squamous ceils of undetermined significance : a prospective study in a Korean population [ J]. Eur J Gynaecol Oncol, 2009,30 (3) :271-274.
  • 7Mayrand MH, Duarte-Franco E, Rodrigues I,et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer[ J]. N Engl J Med, 2007,357 (16) : 1579-1588.
  • 8Perkins RB, Langrish SM, Stern LJ,et al. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned? [ J ]. Trop Med Int Health,2007',12(9) :1018-1025.
  • 9Qiao YL, Sellors JW, Eder PS,et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China [ J ]. Lancet Oncol, 2008,9 (10) :910-911.
  • 10Arbyn M, Sankaranarayanan R, Muwouge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India[ J]. Int J Cancer, 2008,123 ( 1 ) :153-160.

共引文献82

同被引文献13

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部